Effective dosing of a child for the treatment of ADHD with methylphenidate
US11166947B2 · kind B2 · utility
1Cited by
2References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 31, 2017 |
| Grant date | Nov 9, 2021 |
| Priority date | — |
| Expiry date | Jan 25, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention generally relates to treating attention-deficit disorders (e.g., ADHD) by providing an effective amount of an ADHD-effective agent to a patient in need thereof (e.g., a child).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.